Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €59.71 EUR
Change Today -0.60 / -0.99%
Volume 0.0
MAH1 On Other Exchanges
As of 2:05 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

magellan health inc (MAH1) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - €67.23
52 Week Low
08/13/14 - €40.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MAGELLAN HEALTH INC (MAH1)

magellan health inc (MAH1) Related Bloomberg News

View More Bloomberg News

magellan health inc (MAH1) Related Businessweek News

No Related Businessweek News Found

magellan health inc (MAH1) Details

Magellan Health, Inc. engages in the healthcare management business in the United States. The company’s Managed Healthcare Commercial segment offers managed behavioral healthcare services, as well as employee assistance programs services. Its Managed Healthcare Public Sector segment is involved in the management of behavioral health services for recipients under contracts with state and local governmental agencies; and integrated management of physical, behavioral, and pharmaceutical care for special populations covered under Medicaid and other government sponsored programs. The company’s Specialty Solutions segment provides specialty solutions, such as the delivery of diagnostic imaging and various other specialty areas comprising radiation oncology, obstetrical ultrasound, cardiology, and musculoskeletal management. This segment offers specialty solutions under contracts with health plans and insurance companies for its commercial, Medicaid, and Medicare members. Its Pharmacy Management segment provides pharmacy management products and solutions that offer clinical and financial management of drugs paid under medical and pharmacy benefit programs, including traditional pharmacy benefit management (PBM); pharmacy benefit administration for state Medicaid and other government sponsored programs; specialty pharmaceutical dispensing operations, and contracting and formulary optimization programs; medical pharmacy management programs; and programs for the management of specialty drugs, which treat complex conditions, as well as subcontract arrangements to provide PBM services for public sector customers. The company offers its services to health plans, managed care organizations, employers, labor unions, various military and governmental agencies, third party administrators, consultants, brokers, and insurance companies. Magellan Health, Inc. was founded in 1969 and is based in Scottsdale, Arizona.

6,600 Employees
Last Reported Date: 02/26/15
Founded in 1969

magellan health inc (MAH1) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $975.0K
Chief Financial Officer
Total Annual Compensation: $496.8K
Chief Executive Officer of Magellan Healthcar...
Total Annual Compensation: $518.8K
Chief Executive Officer of National Imaging A...
Total Annual Compensation: $450.9K
General Counsel and Secretary
Total Annual Compensation: $430.2K
Compensation as of Fiscal Year 2014.

magellan health inc (MAH1) Key Developments

Magellan Health, Inc. Reports Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year of 2015

Magellan Health, Inc. reported unaudited consolidated financial results for the first quarter ended March 31, 2015. For the quarter, the company’s total net revenue was $980,968,000 compared to $966,475,000 a year ago. Income before income taxes was $49,993,000 compared to $11,327,000 a year ago. Net income attributable to company was $25,720,000 or $0.92 per share, compared to $7,288,000 or $0.28 per share, a year ago. Adjusted net income was $27,306,000 or $0.97 per share, compared to $24,384,000 or $0.94 per share, a year ago. Net cash provided by operating activities was $82,827,000 compared to $44,156,000 a year ago. Capital expenditures were $11,059,000 compared to $21,396,000 a year ago. The increase in revenue between periods resulted primarily from the impact of new business, same store growth and rate increases, and the inclusion of revenues from CDMI in the current year, which were partially offset by the loss of revenues associated with previously announced contract terminations. The decrease in net income is primarily due to the decrease in segment profit and non-cash expenses relating to acquisitions, comprised of $15.0 million of changes in the fair value of contingent consideration, $7.4 million of higher stock compensation expense, and $2.8 million of incremental amortization of acquired intangibles, offset by the tax impact of such items. The majority of the increase in the fair value of contingent consideration is due to an improved outlook for CDMI, resulting in increased estimates of the performance-related earn-outs. The decrease in adjusted net income between periods was mainly due to decreased segment profit. The company provided earnings guidance for the full year of 2015. The company expects revenue of $4.45 billion to $4.69 billion, net income of $45 million to $61 million, and segment profit of $272 million to $292 million. Adjusted net income for the year is now projected to range from $92 million to $104 million. The company is revising its guidance for cash flow from operations to the range of $178 million to $202 million, excluding the net shift of restricted funds between cash and investments. Taking into account the impact of share repurchase activity through April 27, 2015, but not considering any potential future share repurchases, the company’s guidance range for fully diluted EPS is estimated to be $1.67 to $2.26 and for fully diluted adjusted EPS of $3.41 to $3.85, based on an updated 27.0 million average fully diluted shares.

Magellan Health, Inc. Establishes the Magellan Cares Foundation, Inc

Magellan Health, Inc. announced that it has established the Magellan Cares Foundation, Inc., a non-profit, 501(c)(3) organization. The foundation’s mission is to improve the health and well-being of the lives and communities Magellan Health serves. The foundation’s focus will include: National or large-scale health access and quality improvement initiatives. Efforts that help to improve the social supports around a quality healthcare system, such as access to housing, food, clothing or self-improvement opportunities. Local efforts, including legacy initiatives supported by Magellan’s employees. Efforts to support America’s military service members, veterans and wounded warriors. During 2015, the foundation will focus its efforts on fundraising and other logistical needs and will begin accepting grant applications in 2016.

Magellan Health, Inc., Annual General Meeting, May 20, 2015

Magellan Health, Inc., Annual General Meeting, May 20, 2015., at 07:30 US Eastern Standard Time. Location: W Scottsdale Hotel. Agenda: To elect four (4) directors, three (3) of whom will serve until 2018 annual meeting and one (1) of whom will serve until 2017 annual meeting; to approve, in an advisory vote, the compensation of named executive officers; to ratify the appointment of Ernst & Young LLP as independent auditor for fiscal year 2015; and to transact such other business as may properly come before the meeting or any adjournment or postponement thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MAH1:GR €59.71 EUR -0.60

MAH1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amedisys Inc $28.98 USD -0.01
Kindred Healthcare Inc $22.92 USD -0.09
LifePoint Health Inc $76.15 USD +0.38
Select Medical Holdings Corp $16.60 USD +0.20
Universal American Corp/NY $10.39 USD -0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation MAH1 Industry Range
Price/Earnings 29.5x
Price/Sales 0.4x
Price/Book 1.6x
Price/Cash Flow 11.7x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAGELLAN HEALTH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at